

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chemosensory behavior (GO:0007635) | 9.66369618 |
| 2 | protein localization to cilium (GO:0061512) | 6.31790454 |
| 3 | axonemal dynein complex assembly (GO:0070286) | 6.27587224 |
| 4 | ethanol oxidation (GO:0006069) | 5.47778930 |
| 5 | cellular glucuronidation (GO:0052695) | 5.45584998 |
| 6 | uronic acid metabolic process (GO:0006063) | 5.43269298 |
| 7 | glucuronate metabolic process (GO:0019585) | 5.43269298 |
| 8 | regulation of cholesterol biosynthetic process (GO:0045540) | 5.26125411 |
| 9 | negative regulation of interleukin-12 production (GO:0032695) | 5.20728487 |
| 10 | regulation of mononuclear cell migration (GO:0071675) | 5.04796147 |
| 11 | positive regulation of digestive system process (GO:0060456) | 4.67719170 |
| 12 | epoxygenase P450 pathway (GO:0019373) | 4.66357412 |
| 13 | one-carbon compound transport (GO:0019755) | 4.62945632 |
| 14 | motile cilium assembly (GO:0044458) | 4.51246587 |
| 15 | tachykinin receptor signaling pathway (GO:0007217) | 4.43745064 |
| 16 | response to peptidoglycan (GO:0032494) | 4.41611849 |
| 17 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.38493244 |
| 18 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.37792312 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.34779853 |
| 20 | glycosphingolipid catabolic process (GO:0046479) | 4.32795907 |
| 21 | alkaloid metabolic process (GO:0009820) | 4.29508521 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 4.28544024 |
| 23 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.28054317 |
| 24 | exogenous drug catabolic process (GO:0042738) | 4.16351853 |
| 25 | ethanol metabolic process (GO:0006067) | 4.15956336 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 4.06449785 |
| 27 | flavonoid metabolic process (GO:0009812) | 4.05066532 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.94549237 |
| 29 | glycolipid catabolic process (GO:0019377) | 3.86611943 |
| 30 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.84864472 |
| 31 | amino sugar catabolic process (GO:0046348) | 3.83493403 |
| 32 | N-acetylneuraminate metabolic process (GO:0006054) | 3.82521419 |
| 33 | oligosaccharide catabolic process (GO:0009313) | 3.81633019 |
| 34 | T-helper 1 type immune response (GO:0042088) | 3.77826493 |
| 35 | drug catabolic process (GO:0042737) | 3.72898711 |
| 36 | regulation of cholesterol metabolic process (GO:0090181) | 3.70541067 |
| 37 | antibacterial humoral response (GO:0019731) | 3.70054605 |
| 38 | cilium movement (GO:0003341) | 3.64059250 |
| 39 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.62077887 |
| 40 | hormone catabolic process (GO:0042447) | 3.61720675 |
| 41 | negative regulation of lipase activity (GO:0060192) | 3.58007166 |
| 42 | regulation of macrophage chemotaxis (GO:0010758) | 3.57744113 |
| 43 | renal absorption (GO:0070293) | 3.50945854 |
| 44 | myeloid dendritic cell differentiation (GO:0043011) | 3.50811524 |
| 45 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.49291112 |
| 46 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.45476657 |
| 47 | regulation of podosome assembly (GO:0071801) | 3.44543682 |
| 48 | regulation of tolerance induction (GO:0002643) | 3.44119305 |
| 49 | antimicrobial humoral response (GO:0019730) | 3.42538661 |
| 50 | ceramide catabolic process (GO:0046514) | 3.40717405 |
| 51 | NIK/NF-kappaB signaling (GO:0038061) | 3.37660500 |
| 52 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.37344155 |
| 53 | response to thyroid hormone (GO:0097066) | 3.31306194 |
| 54 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.30162632 |
| 55 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.28173291 |
| 56 | regulation of sodium ion transmembrane transport (GO:1902305) | 3.27368420 |
| 57 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.25963880 |
| 58 | regulation of cardioblast proliferation (GO:0003264) | 3.25963880 |
| 59 | response to xenobiotic stimulus (GO:0009410) | 3.25520033 |
| 60 | membrane lipid catabolic process (GO:0046466) | 3.25000104 |
| 61 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.19621369 |
| 62 | omega-hydroxylase P450 pathway (GO:0097267) | 3.18811812 |
| 63 | reactive oxygen species biosynthetic process (GO:1903409) | 3.17996847 |
| 64 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.15984352 |
| 65 | sphingolipid catabolic process (GO:0030149) | 3.15636290 |
| 66 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.15388168 |
| 67 | L-phenylalanine catabolic process (GO:0006559) | 3.14538598 |
| 68 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.14538598 |
| 69 | regulation of cholesterol storage (GO:0010885) | 3.13659274 |
| 70 | regulation of chemokine biosynthetic process (GO:0045073) | 3.13587532 |
| 71 | epithelial cilium movement (GO:0003351) | 3.13530821 |
| 72 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.13296023 |
| 73 | gas transport (GO:0015669) | 3.11251761 |
| 74 | activation of protein kinase A activity (GO:0034199) | 3.11116478 |
| 75 | monocyte chemotaxis (GO:0002548) | 3.11020857 |
| 76 | positive regulation of tolerance induction (GO:0002645) | 3.09939610 |
| 77 | positive regulation of heat generation (GO:0031652) | 3.08122611 |
| 78 | positive regulation of antigen processing and presentation (GO:0002579) | 3.06289035 |
| 79 | barbed-end actin filament capping (GO:0051016) | 3.03842715 |
| 80 | myeloid dendritic cell activation (GO:0001773) | 3.02929226 |
| 81 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.02253978 |
| 82 | protein insertion into membrane (GO:0051205) | 3.02198627 |
| 83 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.99317911 |
| 84 | regulation of mast cell degranulation (GO:0043304) | 2.99073364 |
| 85 | regulation of antigen processing and presentation (GO:0002577) | 2.98908235 |
| 86 | bile acid biosynthetic process (GO:0006699) | 2.98391708 |
| 87 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.98023508 |
| 88 | detection of molecule of bacterial origin (GO:0032490) | 2.97660579 |
| 89 | L-phenylalanine metabolic process (GO:0006558) | 2.97571521 |
| 90 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.97571521 |
| 91 | B cell mediated immunity (GO:0019724) | 2.97178099 |
| 92 | tolerance induction (GO:0002507) | 2.96609784 |
| 93 | negative regulation of cell killing (GO:0031342) | 2.94612175 |
| 94 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.94612175 |
| 95 | granulocyte activation (GO:0036230) | 2.92782435 |
| 96 | virion attachment to host cell (GO:0019062) | 2.92163102 |
| 97 | adhesion of symbiont to host cell (GO:0044650) | 2.92163102 |
| 98 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.91894368 |
| 99 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.90775934 |
| 100 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.88477899 |
| 101 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.87860065 |
| 102 | macrophage activation (GO:0042116) | 2.87750326 |
| 103 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.86896405 |
| 104 | positive regulation by symbiont of host defense response (GO:0052509) | 2.85980617 |
| 105 | modulation by symbiont of host defense response (GO:0052031) | 2.85980617 |
| 106 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.85980617 |
| 107 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.85980617 |
| 108 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.85980617 |
| 109 | modulation by symbiont of host immune response (GO:0052553) | 2.85980617 |
| 110 | high-density lipoprotein particle remodeling (GO:0034375) | 2.84863145 |
| 111 | positive regulation of type 2 immune response (GO:0002830) | 2.84532030 |
| 112 | xenobiotic catabolic process (GO:0042178) | 2.84353714 |
| 113 | dendritic cell differentiation (GO:0097028) | 2.82810746 |
| 114 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.82614758 |
| 115 | cysteine metabolic process (GO:0006534) | 2.81096302 |
| 116 | phenylpropanoid metabolic process (GO:0009698) | 2.79964475 |
| 117 | response to protozoan (GO:0001562) | 2.77690115 |
| 118 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.77625779 |
| 119 | germinal center formation (GO:0002467) | 2.77119808 |
| 120 | eosinophil chemotaxis (GO:0048245) | 2.77040661 |
| 121 | cellular response to arsenic-containing substance (GO:0071243) | 2.76911053 |
| 122 | positive regulation of leukocyte degranulation (GO:0043302) | 2.76274631 |
| 123 | negative regulation of astrocyte differentiation (GO:0048712) | 2.75984292 |
| 124 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.75823721 |
| 125 | positive regulation of mast cell degranulation (GO:0043306) | 2.75823721 |
| 126 | primary alcohol catabolic process (GO:0034310) | 2.74851827 |
| 127 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.74438391 |
| 128 | regulation of sodium ion transport (GO:0002028) | 2.74203193 |
| 129 | positive regulation of steroid metabolic process (GO:0045940) | 2.73502546 |
| 130 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.73212411 |
| 131 | regulation of germinal center formation (GO:0002634) | 2.71969426 |
| 132 | amino-acid betaine metabolic process (GO:0006577) | 2.70907593 |
| 133 | L-ascorbic acid metabolic process (GO:0019852) | 2.70393309 |
| 134 | cellular response to interferon-gamma (GO:0071346) | 2.69728467 |
| 135 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.69337776 |
| 136 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.69252542 |
| 137 | lung epithelium development (GO:0060428) | 2.68485459 |
| 138 | apoptotic cell clearance (GO:0043277) | 2.68367537 |
| 139 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.68152587 |
| 140 | regulation of superoxide anion generation (GO:0032928) | 2.67982041 |
| 141 | carnitine metabolic process (GO:0009437) | 2.66901663 |
| 142 | defense response to protozoan (GO:0042832) | 2.66828634 |
| 143 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.66236853 |
| 144 | cellular response to lipopolysaccharide (GO:0071222) | 2.65991742 |
| 145 | detection of other organism (GO:0098543) | 2.65427969 |
| 146 | cellular copper ion homeostasis (GO:0006878) | 2.65409522 |
| 147 | relaxation of cardiac muscle (GO:0055119) | 2.65103786 |
| 148 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.64241290 |
| 149 | short-chain fatty acid metabolic process (GO:0046459) | 2.63527143 |
| 150 | type I interferon signaling pathway (GO:0060337) | 2.63108314 |
| 151 | cellular response to type I interferon (GO:0071357) | 2.63108314 |
| 152 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.63052080 |
| 153 | detection of external biotic stimulus (GO:0098581) | 2.62688990 |
| 154 | left/right pattern formation (GO:0060972) | 2.62421770 |
| 155 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.62216880 |
| 156 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.61785269 |
| 157 | mating behavior (GO:0007617) | 2.59513154 |
| 158 | auditory receptor cell differentiation (GO:0042491) | 2.58486980 |
| 159 | imidazole-containing compound metabolic process (GO:0052803) | 2.57129052 |
| 160 | positive regulation of hormone metabolic process (GO:0032352) | 2.56832741 |
| 161 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.56364524 |
| 162 | protein carboxylation (GO:0018214) | 2.56364524 |
| 163 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.55318290 |
| 164 | reverse cholesterol transport (GO:0043691) | 2.54275470 |
| 165 | urea cycle (GO:0000050) | 2.51866511 |
| 166 | urea metabolic process (GO:0019627) | 2.51866511 |
| 167 | aromatic amino acid family catabolic process (GO:0009074) | 2.51694881 |
| 168 | positive regulation of macrophage cytokine production (GO:0060907) | 2.51148584 |
| 169 | vitamin biosynthetic process (GO:0009110) | 2.50895995 |
| 170 | lateral ventricle development (GO:0021670) | 2.48207738 |
| 171 | toxin metabolic process (GO:0009404) | 2.47941288 |
| 172 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.47676348 |
| 173 | regulation of fibrinolysis (GO:0051917) | 2.46041112 |
| 174 | alpha-linolenic acid metabolic process (GO:0036109) | 2.45609615 |
| 175 | peptide biosynthetic process (GO:0043043) | 2.43502016 |
| 176 | cAMP biosynthetic process (GO:0006171) | 2.41703679 |
| 177 | regulation of lipoprotein metabolic process (GO:0050746) | 2.40647926 |
| 178 | negative regulation of sodium ion transport (GO:0010766) | 2.38043823 |
| 179 | response to nitrosative stress (GO:0051409) | 2.36126863 |
| 180 | glyoxylate metabolic process (GO:0046487) | 2.35910618 |
| 181 | camera-type eye morphogenesis (GO:0048593) | 2.33608773 |
| 182 | water transport (GO:0006833) | 2.31650944 |
| 183 | cellular modified amino acid catabolic process (GO:0042219) | 2.31424494 |
| 184 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.27607432 |
| 185 | aldehyde catabolic process (GO:0046185) | 2.26821533 |
| 186 | ovulation cycle (GO:0042698) | 2.25831212 |
| 187 | nitrogen cycle metabolic process (GO:0071941) | 2.24527325 |
| 188 | fatty acid oxidation (GO:0019395) | 2.24095820 |
| 189 | benzene-containing compound metabolic process (GO:0042537) | 2.23900664 |
| 190 | negative regulation of fibrinolysis (GO:0051918) | 2.23739576 |
| 191 | bile acid metabolic process (GO:0008206) | 2.23584097 |
| 192 | diterpenoid biosynthetic process (GO:0016102) | 2.22124551 |
| 193 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.22066293 |
| 194 | lipid oxidation (GO:0034440) | 2.21055796 |
| 195 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.20158365 |
| 196 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.18937796 |
| 197 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.18771116 |
| 198 | sensory perception of smell (GO:0007608) | 18.7979756 |
| 199 | sensory perception of chemical stimulus (GO:0007606) | 10.1571650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.50109254 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.28339723 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.91667189 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.83137418 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.83080127 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.38122479 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.34465729 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.20006984 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.99536086 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.98497800 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.97310558 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.86849470 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.85485383 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70059210 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.49296879 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.44736677 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.42510708 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.40069009 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.33603372 |
| 20 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.20801258 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.13968330 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.13573709 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.11332602 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.02327221 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 1.99291151 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.96285298 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.96236873 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.88094763 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.82553220 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80646670 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.80500216 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79831642 |
| 33 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.79521148 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.78659519 |
| 35 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.77570733 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76485268 |
| 37 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.74266867 |
| 38 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.68344150 |
| 39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.67563594 |
| 40 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67181706 |
| 41 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.66662196 |
| 42 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.66662196 |
| 43 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.66078449 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64072597 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63937793 |
| 46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.60513742 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.60460176 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59447567 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.56678935 |
| 50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.55485419 |
| 51 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.55352575 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54165742 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.53977210 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.51147131 |
| 55 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51092209 |
| 56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.49222423 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46137612 |
| 58 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.44488636 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43563378 |
| 60 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.42315965 |
| 61 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.41066561 |
| 62 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.39452140 |
| 63 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.38570386 |
| 64 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.37771406 |
| 65 | MAF_26560356_Chip-Seq_TH1_Human | 1.34818784 |
| 66 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.34087911 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32721005 |
| 68 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.32352611 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32108780 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31939613 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31205398 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30394460 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30350675 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.29357133 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29175794 |
| 76 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28340237 |
| 77 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.28328669 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27104997 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26802149 |
| 80 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26325161 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25224171 |
| 82 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.24570948 |
| 83 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.24189407 |
| 84 | KDM2B_26808549_Chip-Seq_K562_Human | 1.24178753 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23875343 |
| 86 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.23570314 |
| 87 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.23569825 |
| 88 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.23484327 |
| 89 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23379755 |
| 90 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23041629 |
| 91 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22928097 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22787121 |
| 93 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.21799794 |
| 94 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.21751414 |
| 95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21199427 |
| 96 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19434278 |
| 97 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18374343 |
| 98 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.18005458 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17698256 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15480937 |
| 101 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.14151178 |
| 102 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12192609 |
| 103 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11718384 |
| 104 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11364776 |
| 105 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.10797696 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09924333 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09832974 |
| 108 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.09420301 |
| 109 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09055917 |
| 110 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08787038 |
| 111 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07224303 |
| 112 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05850251 |
| 113 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04813938 |
| 114 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03676125 |
| 115 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.03191761 |
| 116 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03146422 |
| 117 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02984292 |
| 118 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02552662 |
| 119 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02408334 |
| 120 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02016813 |
| 121 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01667286 |
| 122 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01657550 |
| 123 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01056274 |
| 124 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00940904 |
| 125 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00309796 |
| 126 | * P68_20966046_ChIP-Seq_HELA_Human | 0.99866477 |
| 127 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99755037 |
| 128 | MAF_26560356_Chip-Seq_TH2_Human | 0.99095663 |
| 129 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98576184 |
| 130 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.98507487 |
| 131 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98419414 |
| 132 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98041608 |
| 133 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97332475 |
| 134 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97185877 |
| 135 | UTX_26944678_Chip-Seq_JUKART_Human | 0.96662670 |
| 136 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.96605190 |
| 137 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.96189905 |
| 138 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94205339 |
| 139 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94191822 |
| 140 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94106973 |
| 141 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.93647988 |
| 142 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93631449 |
| 143 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92953614 |
| 144 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89913274 |
| 145 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.89893019 |
| 146 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.89825869 |
| 147 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89195180 |
| 148 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89193453 |
| 149 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89017132 |
| 150 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88926383 |
| 151 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88859646 |
| 152 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88859646 |
| 153 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.88812394 |
| 154 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.88805213 |
| 155 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88267497 |
| 156 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.88191295 |
| 157 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.87925448 |
| 158 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87728331 |
| 159 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87525253 |
| 160 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87336798 |
| 161 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.87294243 |
| 162 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86510232 |
| 163 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85852251 |
| 164 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83433982 |
| 165 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83369436 |
| 166 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82469254 |
| 167 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.82339487 |
| 168 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81609849 |
| 169 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80510065 |
| 170 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.79568629 |
| 171 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.79434466 |
| 172 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.79073342 |
| 173 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.78483793 |
| 174 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.78241297 |
| 175 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.77060071 |
| 176 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.76967038 |
| 177 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.76823333 |
| 178 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.76172870 |
| 179 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.75589060 |
| 180 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.75512809 |
| 181 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75494269 |
| 182 | GATA1_22025678_ChIP-Seq_K562_Human | 0.75395641 |
| 183 | CBP_21632823_ChIP-Seq_H3396_Human | 0.75143364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008875_abnormal_xenobiotic_pharmacok | 5.81411116 |
| 2 | MP0005499_abnormal_olfactory_system | 5.75858056 |
| 3 | MP0005394_taste/olfaction_phenotype | 5.75858056 |
| 4 | MP0008789_abnormal_olfactory_epithelium | 4.96334839 |
| 5 | MP0003303_peritoneal_inflammation | 4.37173663 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.37415373 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.93308567 |
| 8 | MP0003436_decreased_susceptibility_to | 2.88782105 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.81757499 |
| 10 | MP0009785_altered_susceptibility_to | 2.75154805 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.68272387 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.67204307 |
| 13 | MP0005365_abnormal_bile_salt | 2.61890148 |
| 14 | MP0004510_myositis | 2.57806915 |
| 15 | MP0001790_abnormal_immune_system | 2.55582046 |
| 16 | MP0005387_immune_system_phenotype | 2.55582046 |
| 17 | MP0003879_abnormal_hair_cell | 2.54202054 |
| 18 | MP0002419_abnormal_innate_immunity | 2.53353038 |
| 19 | MP0003724_increased_susceptibility_to | 2.44234082 |
| 20 | MP0005025_abnormal_response_to | 2.40662050 |
| 21 | MP0000343_altered_response_to | 2.32326643 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.30123477 |
| 23 | MP0005671_abnormal_response_to | 2.29076075 |
| 24 | MP0005000_abnormal_immune_tolerance | 2.23238541 |
| 25 | MP0001346_abnormal_lacrimal_gland | 2.05671020 |
| 26 | MP0005360_urolithiasis | 2.02505495 |
| 27 | MP0001984_abnormal_olfaction | 11.6543388 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.96733604 |
| 29 | MP0002254_reproductive_system_inflammat | 1.96500579 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.95103252 |
| 31 | MP0010030_abnormal_orbit_morphology | 1.92282290 |
| 32 | MP0000685_abnormal_immune_system | 1.90632006 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.88765430 |
| 34 | MP0005085_abnormal_gallbladder_physiolo | 1.85054799 |
| 35 | MP0002723_abnormal_immune_serum | 1.82644149 |
| 36 | MP0006054_spinal_hemorrhage | 1.81562146 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.77359713 |
| 38 | MP0001485_abnormal_pinna_reflex | 1.74095510 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.72970027 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.68575997 |
| 41 | MP0001853_heart_inflammation | 1.67553980 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.67098982 |
| 43 | MP0009278_abnormal_bone_marrow | 1.67009696 |
| 44 | MP0001800_abnormal_humoral_immune | 1.65636826 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.65455364 |
| 46 | MP0002233_abnormal_nose_morphology | 1.64005872 |
| 47 | MP0008004_abnormal_stomach_pH | 1.63678801 |
| 48 | MP0008469_abnormal_protein_level | 1.61135752 |
| 49 | MP0010329_abnormal_lipoprotein_level | 1.59246397 |
| 50 | MP0002405_respiratory_system_inflammati | 1.55085883 |
| 51 | MP0000858_altered_metastatic_potential | 1.52759968 |
| 52 | MP0001819_abnormal_immune_cell | 1.49969490 |
| 53 | MP0003448_altered_tumor_morphology | 1.49250534 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.48890823 |
| 55 | MP0010234_abnormal_vibrissa_follicle | 1.45705957 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.41381507 |
| 57 | MP0005166_decreased_susceptibility_to | 1.38066648 |
| 58 | MP0005451_abnormal_body_composition | 1.37836849 |
| 59 | MP0004947_skin_inflammation | 1.36103005 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.33652193 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.33652193 |
| 62 | MP0005248_abnormal_Harderian_gland | 1.29331779 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.23563882 |
| 64 | MP0005165_increased_susceptibility_to | 1.20990285 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.18148912 |
| 66 | MP0008260_abnormal_autophagy | 1.15730638 |
| 67 | MP0003252_abnormal_bile_duct | 1.12152733 |
| 68 | MP0004885_abnormal_endolymph | 1.12046239 |
| 69 | MP0005645_abnormal_hypothalamus_physiol | 1.09223511 |
| 70 | MP0001963_abnormal_hearing_physiology | 1.08829244 |
| 71 | MP0003195_calcinosis | 1.05988556 |
| 72 | MP0005377_hearing/vestibular/ear_phenot | 1.02975165 |
| 73 | MP0003878_abnormal_ear_physiology | 1.02975165 |
| 74 | MP0002876_abnormal_thyroid_physiology | 1.00629560 |
| 75 | MP0001663_abnormal_digestive_system | 1.00601463 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 0.98893913 |
| 77 | MP0000534_abnormal_ureter_morphology | 0.98827518 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 0.98579217 |
| 79 | MP0000613_abnormal_salivary_gland | 0.98296097 |
| 80 | MP0005164_abnormal_response_to | 0.97255570 |
| 81 | MP0002822_catalepsy | 0.96515388 |
| 82 | MP0003075_altered_response_to | 0.96503779 |
| 83 | MP0000604_amyloidosis | 0.96494941 |
| 84 | MP0000716_abnormal_immune_system | 0.95389860 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95208190 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.93736333 |
| 87 | MP0003329_amyloid_beta_deposits | 0.93192708 |
| 88 | MP0009763_increased_sensitivity_to | 0.92729879 |
| 89 | MP0000026_abnormal_inner_ear | 0.92247774 |
| 90 | MP0003828_pulmonary_edema | 0.90715801 |
| 91 | MP0000920_abnormal_myelination | 0.90522120 |
| 92 | MP0004134_abnormal_chest_morphology | 0.89035484 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 0.88828333 |
| 94 | MP0003942_abnormal_urinary_system | 0.88397317 |
| 95 | MP0009780_abnormal_chondrocyte_physiolo | 0.86586707 |
| 96 | MP0002909_abnormal_adrenal_gland | 0.83509701 |
| 97 | MP0002837_dystrophic_cardiac_calcinosis | 0.81967800 |
| 98 | MP0009840_abnormal_foam_cell | 0.80504257 |
| 99 | MP0004883_abnormal_blood_vessel | 0.80237087 |
| 100 | MP0010386_abnormal_urinary_bladder | 0.79900709 |
| 101 | MP0003634_abnormal_glial_cell | 0.79461484 |
| 102 | MP0000609_abnormal_liver_physiology | 0.77060280 |
| 103 | MP0002132_abnormal_respiratory_system | 0.76557835 |
| 104 | MP0005390_skeleton_phenotype | 0.76425454 |
| 105 | MP0002653_abnormal_ependyma_morphology | 0.75290818 |
| 106 | MP0002118_abnormal_lipid_homeostasis | 0.73135598 |
| 107 | MP0003795_abnormal_bone_structure | 0.72566969 |
| 108 | MP0002184_abnormal_innervation | 0.72297120 |
| 109 | MP0009384_cardiac_valve_regurgitation | 0.71584861 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.71315739 |
| 111 | MP0002090_abnormal_vision | 0.69586762 |
| 112 | MP0003186_abnormal_redox_activity | 0.69327286 |
| 113 | MP0002429_abnormal_blood_cell | 0.69267199 |
| 114 | MP0001666_abnormal_nutrient_absorption | 0.68981142 |
| 115 | MP0005367_renal/urinary_system_phenotyp | 0.68390240 |
| 116 | MP0000516_abnormal_urinary_system | 0.68390240 |
| 117 | MP0010307_abnormal_tumor_latency | 0.67445447 |
| 118 | MP0000689_abnormal_spleen_morphology | 0.66683753 |
| 119 | MP0000249_abnormal_blood_vessel | 0.65620675 |
| 120 | MP0005623_abnormal_meninges_morphology | 0.64026345 |
| 121 | MP0009053_abnormal_anal_canal | 0.63455355 |
| 122 | MP0006082_CNS_inflammation | 0.63084699 |
| 123 | MP0005381_digestive/alimentary_phenotyp | 0.63014199 |
| 124 | MP0005647_abnormal_sex_gland | 0.62458376 |
| 125 | MP0009643_abnormal_urine_homeostasis | 0.61795599 |
| 126 | MP0005266_abnormal_metabolism | 0.61101284 |
| 127 | MP0004019_abnormal_vitamin_homeostasis | 0.60983626 |
| 128 | MP0005332_abnormal_amino_acid | 0.60511216 |
| 129 | MP0002398_abnormal_bone_marrow | 0.60104593 |
| 130 | MP0003183_abnormal_peptide_metabolism | 0.59995357 |
| 131 | MP0004858_abnormal_nervous_system | 0.59887869 |
| 132 | MP0001849_ear_inflammation | 0.59249460 |
| 133 | MP0002896_abnormal_bone_mineralization | 0.58019021 |
| 134 | MP0005319_abnormal_enzyme/_coenzyme | 0.57792480 |
| 135 | MP0002277_abnormal_respiratory_mucosa | 0.56663515 |
| 136 | MP0000762_abnormal_tongue_morphology | 0.56534554 |
| 137 | MP0005275_abnormal_skin_tensile | 0.56297127 |
| 138 | MP0005310_abnormal_salivary_gland | 0.55207743 |
| 139 | MP0003690_abnormal_glial_cell | 0.54490893 |
| 140 | MP0001348_abnormal_lacrimal_gland | 0.53478469 |
| 141 | MP0001299_abnormal_eye_distance/ | 0.53438992 |
| 142 | MP0003566_abnormal_cell_adhesion | 0.53283065 |
| 143 | MP0005408_hypopigmentation | 0.52576770 |
| 144 | MP0002752_abnormal_somatic_nervous | 0.52417292 |
| 145 | MP0000049_abnormal_middle_ear | 0.51032391 |
| 146 | MP0008874_decreased_physiological_sensi | 0.50344231 |
| 147 | MP0010678_abnormal_skin_adnexa | 0.48798982 |
| 148 | MP0002249_abnormal_larynx_morphology | 0.47977447 |
| 149 | MP0008438_abnormal_cutaneous_collagen | 0.47492993 |
| 150 | MP0009764_decreased_sensitivity_to | 0.47392450 |
| 151 | MP0002295_abnormal_pulmonary_circulatio | 0.47388040 |
| 152 | MP0002272_abnormal_nervous_system | 0.45914872 |
| 153 | MP0000579_abnormal_nail_morphology | 0.42504258 |
| 154 | MP0002282_abnormal_trachea_morphology | 0.42384310 |
| 155 | MP0005376_homeostasis/metabolism_phenot | 0.40829524 |
| 156 | MP0005508_abnormal_skeleton_morphology | 0.40611957 |
| 157 | MP0005187_abnormal_penis_morphology | 0.39870592 |
| 158 | MP0000465_gastrointestinal_hemorrhage | 0.38450164 |
| 159 | MP0004782_abnormal_surfactant_physiolog | 0.36923882 |
| 160 | MP0002882_abnormal_neuron_morphology | 0.36456007 |
| 161 | MP0005083_abnormal_biliary_tract | 0.36103684 |
| 162 | MP0002098_abnormal_vibrissa_morphology | 0.35077037 |
| 163 | MP0004742_abnormal_vestibular_system | 0.35074843 |
| 164 | MP0000163_abnormal_cartilage_morphology | 0.35015531 |
| 165 | MP0005058_abnormal_lysosome_morphology | 0.34477706 |
| 166 | MP0003938_abnormal_ear_development | 0.34195922 |
| 167 | MP0001542_abnormal_bone_strength | 0.33688221 |
| 168 | MP0003633_abnormal_nervous_system | 0.33155407 |
| 169 | MP0005503_abnormal_tendon_morphology | 0.32399041 |
| 170 | MP0002796_impaired_skin_barrier | 0.32229406 |
| 171 | MP0004043_abnormal_pH_regulation | 0.32091512 |
| 172 | MP0008872_abnormal_physiological_respon | 0.30793518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 6.85843029 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.85843029 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.85843029 |
| 4 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.93929230 |
| 5 | Abnormal respiratory motile cilium morphology (HP:0005938) | 5.44446501 |
| 6 | Abnormal respiratory epithelium morphology (HP:0012253) | 5.44446501 |
| 7 | Absent/shortened dynein arms (HP:0200106) | 5.37192319 |
| 8 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.37192319 |
| 9 | Abnormal respiratory motile cilium physiology (HP:0012261) | 5.19244300 |
| 10 | Abnormal ciliary motility (HP:0012262) | 5.00430280 |
| 11 | Disinhibition (HP:0000734) | 4.87485901 |
| 12 | Rhinitis (HP:0012384) | 4.81397514 |
| 13 | Epiphyseal dysplasia (HP:0002656) | 4.80942229 |
| 14 | Abnormality of the nasal mucosa (HP:0000433) | 4.68373406 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 4.65491077 |
| 16 | Nasal polyposis (HP:0100582) | 4.59051226 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 4.47988151 |
| 18 | Dysostosis multiplex (HP:0000943) | 4.31847813 |
| 19 | Atrioventricular block (HP:0001678) | 4.18512491 |
| 20 | Deep venous thrombosis (HP:0002625) | 4.18420139 |
| 21 | Humeroradial synostosis (HP:0003041) | 4.16967063 |
| 22 | Synostosis involving the elbow (HP:0003938) | 4.16967063 |
| 23 | Lip pit (HP:0100267) | 4.16617903 |
| 24 | Decreased circulating renin level (HP:0003351) | 4.15605604 |
| 25 | Loss of speech (HP:0002371) | 4.08499670 |
| 26 | Bifid scrotum (HP:0000048) | 4.06546987 |
| 27 | Ulnar bowing (HP:0003031) | 4.05652268 |
| 28 | Glomerulonephritis (HP:0000099) | 4.04824245 |
| 29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.86613644 |
| 30 | Recurrent bacterial skin infections (HP:0005406) | 3.84547978 |
| 31 | Abnormality of macrophages (HP:0004311) | 3.82614647 |
| 32 | Recurrent abscess formation (HP:0002722) | 3.73587371 |
| 33 | Chronic bronchitis (HP:0004469) | 3.72007320 |
| 34 | Mutism (HP:0002300) | 3.67744096 |
| 35 | Palpitations (HP:0001962) | 3.65492170 |
| 36 | Bronchiectasis (HP:0002110) | 3.59291584 |
| 37 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.50762460 |
| 38 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.50556034 |
| 39 | Nuclear cataract (HP:0100018) | 3.41099059 |
| 40 | Complement deficiency (HP:0004431) | 3.38176918 |
| 41 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.34596624 |
| 42 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.34596624 |
| 43 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.34596624 |
| 44 | Xanthomatosis (HP:0000991) | 3.31368978 |
| 45 | Axonal loss (HP:0003447) | 3.29960360 |
| 46 | Intrahepatic cholestasis (HP:0001406) | 3.23866722 |
| 47 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.20753835 |
| 48 | Bronchomalacia (HP:0002780) | 3.20107916 |
| 49 | Recurrent sinusitis (HP:0011108) | 3.19962466 |
| 50 | Mucopolysacchariduria (HP:0008155) | 3.16247770 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.16247770 |
| 52 | Severe Myopia (HP:0011003) | 3.13335366 |
| 53 | Syncope (HP:0001279) | 3.07631987 |
| 54 | Autoimmune thrombocytopenia (HP:0001973) | 3.02985845 |
| 55 | Poikilocytosis (HP:0004447) | 3.01800510 |
| 56 | Prolonged QT interval (HP:0001657) | 2.99502308 |
| 57 | Purpura (HP:0000979) | 2.95440146 |
| 58 | Vitreoretinal degeneration (HP:0000655) | 2.93895020 |
| 59 | Hypobetalipoproteinemia (HP:0003563) | 2.93546095 |
| 60 | Hyperlipoproteinemia (HP:0010980) | 2.88025218 |
| 61 | Eczematoid dermatitis (HP:0000976) | 2.86963763 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.86312975 |
| 63 | Arterial tortuosity (HP:0005116) | 2.83158710 |
| 64 | Hyperglycinuria (HP:0003108) | 2.79982285 |
| 65 | Agnosia (HP:0010524) | 2.78583946 |
| 66 | Myositis (HP:0100614) | 2.75393434 |
| 67 | Increased serum ferritin (HP:0003281) | 2.70947501 |
| 68 | Heart block (HP:0012722) | 2.69428651 |
| 69 | Limb dystonia (HP:0002451) | 2.69030551 |
| 70 | Abnormality of dentin (HP:0010299) | 2.65298970 |
| 71 | Inappropriate behavior (HP:0000719) | 2.63014583 |
| 72 | Bowing of the arm (HP:0006488) | 2.61457419 |
| 73 | Bowed forearm bones (HP:0003956) | 2.61457419 |
| 74 | Orchitis (HP:0100796) | 2.57756449 |
| 75 | Apathy (HP:0000741) | 2.56693891 |
| 76 | Mediastinal lymphadenopathy (HP:0100721) | 2.56371965 |
| 77 | Torticollis (HP:0000473) | 2.56229287 |
| 78 | Amyloidosis (HP:0011034) | 2.55725950 |
| 79 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.55052113 |
| 80 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.54235010 |
| 81 | Metaphyseal irregularity (HP:0003025) | 2.53902282 |
| 82 | Abnormal atrioventricular conduction (HP:0005150) | 2.51779611 |
| 83 | Male infertility (HP:0003251) | 2.51177029 |
| 84 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.50688856 |
| 85 | Abnormality of glycine metabolism (HP:0010895) | 2.50688856 |
| 86 | Diminished motivation (HP:0000745) | 2.50644265 |
| 87 | Bell-shaped thorax (HP:0001591) | 2.50492258 |
| 88 | Vascular tortuosity (HP:0004948) | 2.48792198 |
| 89 | Vaginal fistula (HP:0004320) | 2.47436406 |
| 90 | Upper motor neuron abnormality (HP:0002127) | 2.46773723 |
| 91 | Neuronal loss in central nervous system (HP:0002529) | 2.44782215 |
| 92 | Retrobulbar optic neuritis (HP:0100654) | 2.44355815 |
| 93 | Optic neuritis (HP:0100653) | 2.44355815 |
| 94 | Hyperglycinemia (HP:0002154) | 2.44334149 |
| 95 | Hyperaldosteronism (HP:0000859) | 2.44057341 |
| 96 | Choanal stenosis (HP:0000452) | 2.39090218 |
| 97 | Abnormality of complement system (HP:0005339) | 2.36937588 |
| 98 | Ketosis (HP:0001946) | 2.36835256 |
| 99 | Stomatitis (HP:0010280) | 2.36522451 |
| 100 | Personality changes (HP:0000751) | 2.34592920 |
| 101 | Abnormality of the common coagulation pathway (HP:0010990) | 2.33805180 |
| 102 | Ketoacidosis (HP:0001993) | 2.31620134 |
| 103 | Hydroxyprolinuria (HP:0003080) | 2.30516995 |
| 104 | Abnormality of proline metabolism (HP:0010907) | 2.30516995 |
| 105 | Prolonged partial thromboplastin time (HP:0003645) | 2.30500568 |
| 106 | Abnormality of sodium homeostasis (HP:0010931) | 2.30193537 |
| 107 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.28484191 |
| 108 | Systemic lupus erythematosus (HP:0002725) | 2.27734837 |
| 109 | Tarsal synostosis (HP:0008368) | 2.27153340 |
| 110 | Retinal atrophy (HP:0001105) | 2.26154029 |
| 111 | Craniofacial dystonia (HP:0012179) | 2.24128320 |
| 112 | Hypolipoproteinemia (HP:0010981) | 2.23845985 |
| 113 | Dysphonia (HP:0001618) | 2.22522419 |
| 114 | Recurrent otitis media (HP:0000403) | 2.22241306 |
| 115 | Progressive neurologic deterioration (HP:0002344) | 2.21746074 |
| 116 | Hypoplastic ischia (HP:0003175) | 2.21207927 |
| 117 | Turricephaly (HP:0000262) | 2.21026696 |
| 118 | Protuberant abdomen (HP:0001538) | 2.19700144 |
| 119 | Abnormality of renin-angiotensin system (HP:0000847) | 2.18877922 |
| 120 | Femoral bowing (HP:0002980) | 2.17715777 |
| 121 | Epidermoid cyst (HP:0200040) | 2.15942870 |
| 122 | Synostosis involving bones of the feet (HP:0009140) | 2.15839558 |
| 123 | Synostosis involving bones of the lower limbs (HP:0009138) | 2.15839558 |
| 124 | Chronic sinusitis (HP:0011109) | 2.14896521 |
| 125 | Right ventricular cardiomyopathy (HP:0011663) | 2.14651240 |
| 126 | Fat malabsorption (HP:0002630) | 2.14516327 |
| 127 | Infertility (HP:0000789) | 2.12868232 |
| 128 | Bronchitis (HP:0012387) | 2.12853763 |
| 129 | Hyperammonemia (HP:0001987) | 2.12700674 |
| 130 | Delayed CNS myelination (HP:0002188) | 2.12348931 |
| 131 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11966078 |
| 132 | Obstructive lung disease (HP:0006536) | 2.11966078 |
| 133 | Dementia (HP:0000726) | 2.11662609 |
| 134 | Hepatocellular carcinoma (HP:0001402) | 2.11137395 |
| 135 | Labial hypoplasia (HP:0000066) | 2.11054594 |
| 136 | Protrusio acetabuli (HP:0003179) | 2.09225797 |
| 137 | Cerebral inclusion bodies (HP:0100314) | 2.08807168 |
| 138 | Osteoarthritis (HP:0002758) | 2.08109434 |
| 139 | Abnormal cartilage morphology (HP:0002763) | 2.06332501 |
| 140 | Xerostomia (HP:0000217) | 2.06039547 |
| 141 | Hypoalphalipoproteinemia (HP:0003233) | 2.05091176 |
| 142 | Nephritis (HP:0000123) | 2.04631146 |
| 143 | Morphological abnormality of the middle ear (HP:0008609) | 2.04425091 |
| 144 | Chronic otitis media (HP:0000389) | 2.04225280 |
| 145 | Abnormality of iron homeostasis (HP:0011031) | 2.03908995 |
| 146 | Abnormality of the ischium (HP:0003174) | 2.02957434 |
| 147 | Mild short stature (HP:0003502) | 2.02065925 |
| 148 | Basal ganglia calcification (HP:0002135) | 2.02009433 |
| 149 | Focal dystonia (HP:0004373) | 2.01914931 |
| 150 | Hypothermia (HP:0002045) | 2.01725981 |
| 151 | Prolonged neonatal jaundice (HP:0006579) | 2.01701218 |
| 152 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.01193975 |
| 153 | Abnormality of the vitreous humor (HP:0004327) | 2.01028853 |
| 154 | Malnutrition (HP:0004395) | 1.99916926 |
| 155 | Abnormal EKG (HP:0003115) | 1.99870546 |
| 156 | Anosmia (HP:0000458) | 1.99805932 |
| 157 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.99189966 |
| 158 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.98910033 |
| 159 | Neurofibrillary tangles (HP:0002185) | 1.98661083 |
| 160 | Mixed hearing impairment (HP:0000410) | 1.98428719 |
| 161 | Hematochezia (HP:0002573) | 1.97041433 |
| 162 | Polydipsia (HP:0001959) | 1.95285257 |
| 163 | Abnormal drinking behavior (HP:0030082) | 1.95285257 |
| 164 | Myocardial infarction (HP:0001658) | 1.93538945 |
| 165 | Pulmonary embolism (HP:0002204) | 1.92461323 |
| 166 | Recurrent skin infections (HP:0001581) | 1.92208402 |
| 167 | Cholelithiasis (HP:0001081) | 1.89081683 |
| 168 | Carpal synostosis (HP:0009702) | 1.88607295 |
| 169 | Esophageal varix (HP:0002040) | 1.87777701 |
| 170 | Skin nodule (HP:0200036) | 1.87312231 |
| 171 | Pathologic fracture (HP:0002756) | 1.86303765 |
| 172 | Abnormality of macular pigmentation (HP:0008002) | 1.85023575 |
| 173 | Abnormality of the intrinsic pathway (HP:0010989) | 1.83886453 |
| 174 | Memory impairment (HP:0002354) | 1.83199219 |
| 175 | Renal tubular acidosis (HP:0001947) | 1.82719325 |
| 176 | Abnormal gallbladder morphology (HP:0012437) | 1.82565665 |
| 177 | Pulmonary infiltrates (HP:0002113) | 1.82455430 |
| 178 | Flattened epiphyses (HP:0003071) | 1.80157604 |
| 179 | Primary atrial arrhythmia (HP:0001692) | 1.79730901 |
| 180 | Hepatosplenomegaly (HP:0001433) | 1.78892518 |
| 181 | Asymmetric septal hypertrophy (HP:0001670) | 1.78416015 |
| 182 | Polyneuropathy (HP:0001271) | 1.77904689 |
| 183 | Supranuclear gaze palsy (HP:0000605) | 1.76048555 |
| 184 | Urinary incontinence (HP:0000020) | 1.70141196 |
| 185 | Thoracic kyphosis (HP:0002942) | 1.69712155 |
| 186 | Gingivitis (HP:0000230) | 1.69174571 |
| 187 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.67595639 |
| 188 | Hemoptysis (HP:0002105) | 1.67223233 |
| 189 | Abnormality of the periventricular white matter (HP:0002518) | 1.66610967 |
| 190 | Spontaneous hematomas (HP:0007420) | 1.66508936 |
| 191 | Petechiae (HP:0000967) | 1.66381151 |
| 192 | Atelectasis (HP:0100750) | 1.66340680 |
| 193 | Peripheral demyelination (HP:0011096) | 1.64492761 |
| 194 | Interstitial pulmonary disease (HP:0006530) | 1.63445943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DDR2 | 5.14866215 |
| 2 | NME2 | 4.24146409 |
| 3 | IRAK3 | 3.91557738 |
| 4 | MAPK15 | 3.45452121 |
| 5 | LATS1 | 3.45013299 |
| 6 | BLK | 3.18836719 |
| 7 | STK16 | 3.09248020 |
| 8 | GRK7 | 2.87094851 |
| 9 | TBK1 | 2.75848417 |
| 10 | TRIB3 | 2.75497170 |
| 11 | MAP3K11 | 2.63098402 |
| 12 | PAK3 | 2.61262661 |
| 13 | TYRO3 | 2.59908094 |
| 14 | ERBB3 | 2.50952122 |
| 15 | SIK1 | 2.48741029 |
| 16 | MAP3K3 | 2.43548139 |
| 17 | TAOK2 | 2.28334629 |
| 18 | RIPK1 | 2.10299426 |
| 19 | MATK | 2.10026676 |
| 20 | TAOK1 | 2.08102119 |
| 21 | RIPK4 | 1.96516150 |
| 22 | EPHA3 | 1.93880166 |
| 23 | CAMK2D | 1.93709867 |
| 24 | STK39 | 1.90485401 |
| 25 | CAMK2B | 1.89091901 |
| 26 | FGR | 1.86362021 |
| 27 | IKBKB | 1.82598950 |
| 28 | DAPK2 | 1.82267241 |
| 29 | PIM2 | 1.80874038 |
| 30 | PKN2 | 1.77754928 |
| 31 | ABL2 | 1.71890193 |
| 32 | SIK2 | 1.70723174 |
| 33 | EPHB1 | 1.69809131 |
| 34 | ACVR1B | 1.69524932 |
| 35 | FER | 1.66975995 |
| 36 | LMTK2 | 1.64536403 |
| 37 | DYRK1B | 1.62275564 |
| 38 | CAMK2G | 1.58505189 |
| 39 | IKBKE | 1.55250050 |
| 40 | NTRK1 | 1.53344045 |
| 41 | PTK6 | 1.49252779 |
| 42 | IRAK4 | 1.46206313 |
| 43 | FGFR4 | 1.43331688 |
| 44 | CSNK1A1L | 1.41855480 |
| 45 | BCKDK | 1.41193201 |
| 46 | HIPK2 | 1.39604496 |
| 47 | ERN1 | 1.37460038 |
| 48 | FRK | 1.35698528 |
| 49 | CDC42BPA | 1.33671317 |
| 50 | MAP2K3 | 1.32216156 |
| 51 | MAP4K1 | 1.31660035 |
| 52 | GRK6 | 1.27956037 |
| 53 | ADRBK2 | 1.26262427 |
| 54 | CAMKK2 | 1.25352169 |
| 55 | TGFBR2 | 1.21608422 |
| 56 | ZAP70 | 1.19341600 |
| 57 | JAK3 | 1.19190438 |
| 58 | CSNK1G3 | 1.17161396 |
| 59 | MAP3K10 | 1.14789195 |
| 60 | MAP3K7 | 1.14296990 |
| 61 | MST1R | 1.13764521 |
| 62 | CSNK1G1 | 1.13000077 |
| 63 | TRPM7 | 1.09762074 |
| 64 | MAPKAPK3 | 1.09309596 |
| 65 | MOS | 1.07470497 |
| 66 | CSNK1G2 | 1.07390758 |
| 67 | MAP3K2 | 1.05568046 |
| 68 | CSF1R | 1.05549820 |
| 69 | CHUK | 1.03963657 |
| 70 | LYN | 1.01197202 |
| 71 | NUAK1 | 0.98762320 |
| 72 | MAP3K1 | 0.98234678 |
| 73 | MAP2K1 | 0.95455651 |
| 74 | PAK6 | 0.90312266 |
| 75 | LRRK2 | 0.89320887 |
| 76 | CDK6 | 0.89163548 |
| 77 | TXK | 0.87937475 |
| 78 | PDGFRA | 0.87817483 |
| 79 | PRKCG | 0.86387873 |
| 80 | MAP3K14 | 0.85469121 |
| 81 | MAP2K4 | 0.84450816 |
| 82 | SYK | 0.82958136 |
| 83 | SMG1 | 0.80939694 |
| 84 | KSR2 | 0.79381808 |
| 85 | ALK | 0.77467241 |
| 86 | ARAF | 0.76352240 |
| 87 | ITK | 0.76287868 |
| 88 | FES | 0.75213449 |
| 89 | MARK3 | 0.74275092 |
| 90 | ERBB2 | 0.72180242 |
| 91 | MARK2 | 0.71774931 |
| 92 | PRPF4B | 0.71388208 |
| 93 | MAP3K13 | 0.71173740 |
| 94 | TGFBR1 | 0.70759844 |
| 95 | SIK3 | 0.70620528 |
| 96 | BMPR2 | 0.70362059 |
| 97 | EPHB2 | 0.69860377 |
| 98 | EEF2K | 0.69269317 |
| 99 | MET | 0.69118103 |
| 100 | JAK2 | 0.68518812 |
| 101 | INSRR | 0.67102341 |
| 102 | PRKD1 | 0.65933510 |
| 103 | EPHA2 | 0.65849606 |
| 104 | WNK4 | 0.65376075 |
| 105 | MAP3K5 | 0.65061606 |
| 106 | STK10 | 0.65031147 |
| 107 | TESK2 | 0.64006675 |
| 108 | FGFR2 | 0.63616889 |
| 109 | PRKG2 | 0.63542549 |
| 110 | STK3 | 0.63524505 |
| 111 | PRKCH | 0.62565040 |
| 112 | CAMK1D | 0.62235932 |
| 113 | ERBB4 | 0.61808981 |
| 114 | TESK1 | 0.60909220 |
| 115 | MAP2K2 | 0.59958831 |
| 116 | MAP2K6 | 0.59890190 |
| 117 | PDK2 | 0.59586415 |
| 118 | PTK2 | 0.58097839 |
| 119 | OXSR1 | 0.57937281 |
| 120 | LCK | 0.57633323 |
| 121 | PDPK1 | 0.56879972 |
| 122 | CAMK2A | 0.56518778 |
| 123 | ROCK2 | 0.53793565 |
| 124 | STK24 | 0.53762413 |
| 125 | PINK1 | 0.53166893 |
| 126 | JAK1 | 0.52722167 |
| 127 | MINK1 | 0.52549951 |
| 128 | RET | 0.52097725 |
| 129 | TNK2 | 0.51969099 |
| 130 | ILK | 0.51801027 |
| 131 | PRKCI | 0.51676775 |
| 132 | BTK | 0.50667995 |
| 133 | BMX | 0.50649073 |
| 134 | PRKCZ | 0.50217946 |
| 135 | DMPK | 0.49925593 |
| 136 | CSK | 0.48944166 |
| 137 | IRAK2 | 0.47804110 |
| 138 | HCK | 0.47240928 |
| 139 | TYK2 | 0.46161559 |
| 140 | PAK4 | 0.45175243 |
| 141 | ABL1 | 0.44022568 |
| 142 | FYN | 0.42714593 |
| 143 | IRAK1 | 0.41685496 |
| 144 | ICK | 0.41374469 |
| 145 | DYRK3 | 0.41101280 |
| 146 | CAMKK1 | 0.40672497 |
| 147 | PRKCD | 0.40398753 |
| 148 | RPS6KL1 | 0.40359383 |
| 149 | RPS6KC1 | 0.40359383 |
| 150 | MAPK4 | 0.39178291 |
| 151 | FGFR3 | 0.38613803 |
| 152 | PDK4 | 0.37916159 |
| 153 | PDK3 | 0.37916159 |
| 154 | PRKD3 | 0.37834875 |
| 155 | CDK5 | 0.37111302 |
| 156 | PAK2 | 0.36503499 |
| 157 | RPS6KB2 | 0.36321270 |
| 158 | KIT | 0.35782448 |
| 159 | MAP3K4 | 0.34219113 |
| 160 | NEK9 | 0.33662172 |
| 161 | PRKACG | 0.33077131 |
| 162 | PHKG2 | 0.32748431 |
| 163 | PHKG1 | 0.32748431 |
| 164 | MAP3K12 | 0.31606148 |
| 165 | RPS6KA6 | 0.31436635 |
| 166 | TTN | 0.31222508 |
| 167 | PDK1 | 0.30761822 |
| 168 | PAK1 | 0.30385289 |
| 169 | RPS6KA2 | 0.30302007 |
| 170 | MST4 | 0.30284139 |
| 171 | LIMK1 | 0.30101335 |
| 172 | PKN1 | 0.25647313 |
| 173 | TLK1 | 0.24996631 |
| 174 | EGFR | 0.24668775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 5.02286358 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.90731859 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.64716156 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 3.48288363 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.41315701 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.08904284 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.94767391 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.93298251 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.77600113 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.61526330 |
| 11 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.56391685 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.54663499 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.48114571 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.45499468 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.41230275 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 2.34218142 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.33630429 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.31775886 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.31268787 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.27219001 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.25824721 |
| 22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.24677527 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.23128560 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.21049306 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.20284895 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.09918139 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 2.09413431 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 2.06743576 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.05987302 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.04235678 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.04093379 |
| 32 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.97914967 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.93140546 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.92975641 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92499337 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.91573465 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90640854 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.81575890 |
| 39 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.79080759 |
| 40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.76293725 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.73937564 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.69667828 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.65072762 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.64528674 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.54619591 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.53789037 |
| 47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.53510413 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.51023376 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.49476971 |
| 50 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.48304747 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.48143804 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45037494 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39643955 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39194293 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.36649596 |
| 56 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.28778212 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26835734 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.26717360 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26603610 |
| 60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.25558640 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.23695015 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.22848167 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22325228 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20711700 |
| 65 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.18695757 |
| 66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15598429 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 1.15454568 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.09278639 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.08912622 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.06649742 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06637835 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04514240 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 1.04154671 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.98731327 |
| 75 | Salivary secretion_Homo sapiens_hsa04970 | 0.98536321 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.95751824 |
| 77 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.95562592 |
| 78 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.94036993 |
| 79 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.88034514 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.87940140 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86067047 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84885850 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84341317 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82982865 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82297786 |
| 86 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81789567 |
| 87 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80984266 |
| 88 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.78501652 |
| 89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78281258 |
| 90 | Peroxisome_Homo sapiens_hsa04146 | 0.76927384 |
| 91 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.75392617 |
| 92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.73308492 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.72928565 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.71691061 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71437350 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70598230 |
| 97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68398622 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67906459 |
| 99 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.67280638 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.66003750 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | 0.64240396 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64140479 |
| 103 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64128904 |
| 104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62999882 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62124257 |
| 106 | Morphine addiction_Homo sapiens_hsa05032 | 0.61764973 |
| 107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61639106 |
| 108 | Shigellosis_Homo sapiens_hsa05131 | 0.60993145 |
| 109 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60422808 |
| 110 | Measles_Homo sapiens_hsa05162 | 0.58345879 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57585699 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56404760 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56239945 |
| 114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51950754 |
| 115 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50944061 |
| 116 | Insulin secretion_Homo sapiens_hsa04911 | 0.47723694 |
| 117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47297846 |
| 118 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46950575 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46872781 |
| 120 | Circadian entrainment_Homo sapiens_hsa04713 | 0.46621541 |
| 121 | GABAergic synapse_Homo sapiens_hsa04727 | 0.44298561 |
| 122 | Hepatitis B_Homo sapiens_hsa05161 | 0.43966105 |
| 123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.41416776 |
| 124 | Endocytosis_Homo sapiens_hsa04144 | 0.38880638 |
| 125 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38342193 |
| 126 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38295984 |
| 127 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36946031 |
| 128 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.36844277 |
| 129 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36426583 |
| 130 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36124565 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35455384 |
| 132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35221762 |
| 133 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.35032336 |
| 134 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.34921944 |
| 135 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.34785391 |
| 136 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.34764963 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31152299 |
| 138 | Melanogenesis_Homo sapiens_hsa04916 | 0.30522854 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.29307416 |
| 140 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28995459 |
| 141 | Amoebiasis_Homo sapiens_hsa05146 | 0.28069341 |
| 142 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.28018701 |
| 143 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.25139350 |
| 144 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.24925992 |
| 145 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24682256 |
| 146 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.24419692 |
| 147 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.24419425 |
| 148 | Taste transduction_Homo sapiens_hsa04742 | 0.23929054 |
| 149 | Carbon metabolism_Homo sapiens_hsa01200 | 0.23827722 |
| 150 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23818765 |
| 151 | Axon guidance_Homo sapiens_hsa04360 | 0.23162227 |
| 152 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21899155 |
| 153 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21866371 |
| 154 | Insulin resistance_Homo sapiens_hsa04931 | 0.20404248 |
| 155 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.20390724 |
| 156 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.19503881 |
| 157 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.19151399 |
| 158 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18331195 |
| 159 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.18015983 |
| 160 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.17916310 |
| 161 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.17749504 |
| 162 | HTLV-I infection_Homo sapiens_hsa05166 | 0.17429759 |
| 163 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17125617 |
| 164 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.16624127 |
| 165 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.16337207 |
| 166 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.16288806 |
| 167 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.15637326 |
| 168 | Mineral absorption_Homo sapiens_hsa04978 | 0.15368677 |
| 169 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.14259605 |
| 170 | Lysine degradation_Homo sapiens_hsa00310 | 0.13200250 |
| 171 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.12452496 |
| 172 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.12069062 |
| 173 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.11938077 |
| 174 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.04288189 |

